BioTrove, Inc. Completes a $15 Million Financing Round

Woburn, MA, March 8, 2006 - BioTrove, Inc. announced today that the company has successfully completed its latest fundraising by closing an additional $7 million in an oversubscribed round of venture capital funding. This brings the total amount raised since July 2005 to $15 million. Participating investors include Catalyst Health and Technology Partners, Echelon Ventures, Fletcher Spaght, and CB Health Ventures. The proceeds of this round will accelerate the commercialization of BioTrove’s OpenArray™ genomics and RapidFire™ pharmaceutical screening products.

Source: BioTrove